BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25566910)

  • 21. Recurrent pericarditis and cardiac tamponade in a patient with hypocomplementemic urticarial vasculitis syndrome.
    Babajanians A; Chung-Park M; Wisnieski JJ
    J Rheumatol; 1991 May; 18(5):752-5. PubMed ID: 1865426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed cold urticaria.
    Bäck O; Larsen A
    Acta Derm Venereol; 1978; 58(4):369-71. PubMed ID: 82339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normocomplementemic urticarial vasculitis inaugurating destructive polyarthritis.
    Taillandier J; Alemanni M; Emile JF
    Joint Bone Spine; 2001 Dec; 68(6):510-2. PubMed ID: 11808989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrotizing vasculitis due to gefitinib (Iressa).
    Fernández-Guarino M; Ryan AM; Pérez-García B; Gónzalez-López C; Olasolo PJ
    Int J Dermatol; 2007 Aug; 46(8):890-1. PubMed ID: 17651185
    [No Abstract]   [Full Text] [Related]  

  • 25. Urticarial vasculitis induced by centrally acting appetite suppressants.
    Papadavid E; Yu RC; Tay A; Chu AC
    Br J Dermatol; 1996 May; 134(5):990-1. PubMed ID: 8736361
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenetic studies in chronic urticaria. Failure to demonstrate vasculitis, complement activation and fibrinolysis.
    Boonk WJ; Nieboer C; Huijgens PC
    Dermatologica; 1986; 173(6):264-70. PubMed ID: 2434368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urticaria, angioedema and complement abnormalities].
    Doutre MS
    Allerg Immunol (Paris); 1993 Oct; 25(8):339-40. PubMed ID: 8267845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urticarial vasculitis in an infant.
    Koch PE; Lazova R; Rosen JR; Antaya RJ
    Cutis; 2008 Jan; 81(1):49-52. PubMed ID: 18306848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crescentic membranoproliferative glomerulonephritis and hypocomplementemic urticarial vasculitis.
    Enríquez R; Sirvent AE; Amorós F; Pérez M; Matarredona J; Reyes A
    J Nephrol; 2005; 18(3):318-22. PubMed ID: 16013022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
    Chodorowska G; Czelej D; Niewiedzioł M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histologic variants of drug-induced toxicoderma].
    Thomine E
    Ann Pathol; 1992; 12(4-5):268-75. PubMed ID: 1466683
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous adverse drug reaction to heparins with hypereosinophilia and high IgE level.
    Klos K; Spiewak R; Kruszewski J; Bant A
    Contact Dermatitis; 2011 Jan; 64(1):61-2. PubMed ID: 21166821
    [No Abstract]   [Full Text] [Related]  

  • 33. Interstitial granulomatous drug reaction presenting as erythroderma: remission after discontinuation of enalapril maleate.
    Chen YC; Hsiao CH; Tsai TF
    Br J Dermatol; 2008 May; 158(5):1143-5. PubMed ID: 18284384
    [No Abstract]   [Full Text] [Related]  

  • 34. Generalized pustular eruption associated with converting enzyme inhibitor therapy.
    Carroll J; Thaler M; Grossman E; Alder A; Trau H; Rosenthal T
    Cutis; 1995 Nov; 56(5):276-8. PubMed ID: 8565612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of urticaria after diphencyprone therapy in patients with viral warts.
    Choi JE; Seo SH; Kim IH; Son SW
    Int J Dermatol; 2007 Dec; 46(12):1313-4. PubMed ID: 18173535
    [No Abstract]   [Full Text] [Related]  

  • 36. Methazolamide-induced skin eruptions.
    Gandham SB; Spaeth GL; Di Leonardo M; Costa VP
    Arch Ophthalmol; 1993 Mar; 111(3):370-2. PubMed ID: 8447749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized urticaria with use of diphencyprone in the treatment of warts.
    Culp BL; Wells MJ
    J Drugs Dermatol; 2007 May; 6(5):529-30. PubMed ID: 17679188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis.
    Magro CM; Momtahen S; Harp J
    Eur J Dermatol; 2017 Feb; 27(1):91-92. PubMed ID: 27748260
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypocomplementemic urticarial vasculitis and lower cranial nerve palsies.
    Koul PA; Wahid A; Shah SU; Koul AN; Saleem SM
    J Assoc Physicians India; 2000 May; 48(5):536-7. PubMed ID: 11273153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple H1-antihistamine-induced urticaria.
    Inomata N; Tatewaki S; Ikezawa Z
    J Dermatol; 2009 Apr; 36(4):224-7. PubMed ID: 19348661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.